Skip to content
Open access

AMIUgraph: analysis and modeling of interactions for utility-driven benchmarking of graph-based models in healthcare.

Jul 2026 · BMC Medical Informatics and Decision Making · 0 citations
Medicine

TL;DR

AMIUGraph provides a clinically grounded and utility-driven benchmarking framework that jointly evaluates KGE and GNN models across multiple healthcare graph types and learning settings, and offers practical guidance for selecting graph-based models in medical decision-support systems.

Abstract

Background

Graph-based machine learning approaches, including Knowledge Graph Embedding (KGE) methods and Graph Neural Networks (GNNs), have emerged as powerful tools for modeling complex biomedical data. However, a systematic and clinically grounded comparison of these approaches across heterogeneous healthcare graphs, accounting for both predictive performance and real-world deployment constraints, is still lacking.

Methods

We introduce AMIUGraph, a comprehensive benchmarking framework for healthcare link prediction that integrates real-world clinical data with external biomedical knowledge bases. AMIUGraph evaluates eight state-of-the-art models, of which four are knowledge graph embedding (KGE) methods DistMult, CP, ComplEx, and ConvE and four are graph neural network (GNN) architectures GCN, GraphSAGE, GAT, and GIN. The models are evaluated across three heterogeneous bipartite graphs representing Patients-Diseases, Diseases-Drugs, and Drugs-Targets interactions. Models are assessed under both transductive and inductive learning settings using accuracy, AUC, precision, recall, F1-score, and training time as evaluation metrics.

Results

Experimental results show that model performance is strongly influenced by graph structure and sparsity. GNNs consistently achieve superior predictive performance on sparse interaction graphs, particularly for Diseases-Drugs and Drugs-Targets prediction tasks. In contrast, KGE models demonstrate competitive accuracy with substantially lower computational costs in inductive clinical scenarios involving unseen patients. These trends are especially relevant in clinically realistic settings characterized by multimorbidity, such as gastrointestinal and liver diseases, where frequent patient updates and complex therapeutic interactions are common.

Conclusion

AMIUGraph provides a clinically grounded and utility-driven benchmarking framework that jointly evaluates KGE and GNN models across multiple healthcare graph types and learning settings. The findings offer practical guidance for selecting graph-based models in medical decision-support systems, including applications in gastrointestinal healthcare, while promoting transparency and reproducibility through the public release of all datasets, protocols, and code.

Read PDF

Similar papers

Open access Jan 2026

engGNN: A Dual-Graph Neural Network for Omics-Based Disease Classification and Feature Selection

The proposed engGNN is highlighted as a robust, flexible, and interpretable framework for disease classification and biomarker discovery in high-dimensional omics contexts and provides interpretable feature importance scores that facilitate biologically meaningful discoveries, such as pathway enrichment analysis.

Tian-Tian Yang, Yuxuan Wang, Zhen-Wei Zhou et al. · 0 citations
Open access Aug 2026

Evaluating Graph Neural Network Architectures for Multi-Omics Cancer Subtyping using Methylation and Gene Expression Profiles

A benchmarking study on multiple GNNs on a Protein-Protein Interaction (PPI) network for Kidney Renal Clear Cell Carcinoma and Breast cancer subtype prediction, performing an in-depth investigation of architectures, incorporating skip connections and various data modalities.

Julia Schirmacher, M. C. Maurer, J. M. Metsch et al. · 0 citations
Open access Oct 2026

A benchmark study comparing deep learning and path analysis approaches for multi-class link prediction on a disease-specific literature knowledge graph.

Identifying and understanding multi-type drug-drug interactions and their associated toxicities is crucial for preventing adverse outcomes, especially in vulnerable populations, such as cancer patients, who may already have compromised health statuses. This paper provides a benchmark study that compares various commonl...

Marios Vottas, Konstantinos Bougiatiotis, Fotis Aisopos et al. · 0 citations
Sep 2026

X-GCN: An Explainable and Uncertainty-Aware Graph Convolutional Framework for Multi-Omics Disease Risk Prediction

To provide accurate and helpful insights, healthcare early illness risk prediction requires the integration of diverse multi-omics data. Unlike existing models (MOGONet, ExplainMix, CNNs), X-GCN presents an integrated explainable graph-based framework that combines graph convolution with hierarchical attention in a uni...

Suresh Kulandaivelu, Mohan Mani · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.